JP2016000739A5 - - Google Patents

Download PDF

Info

Publication number
JP2016000739A5
JP2016000739A5 JP2015139845A JP2015139845A JP2016000739A5 JP 2016000739 A5 JP2016000739 A5 JP 2016000739A5 JP 2015139845 A JP2015139845 A JP 2015139845A JP 2015139845 A JP2015139845 A JP 2015139845A JP 2016000739 A5 JP2016000739 A5 JP 2016000739A5
Authority
JP
Japan
Prior art keywords
xrpd
pattern
diffractometer
angstroms
angles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015139845A
Other languages
English (en)
Japanese (ja)
Other versions
JP6404186B2 (ja
JP2016000739A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016000739A publication Critical patent/JP2016000739A/ja
Publication of JP2016000739A5 publication Critical patent/JP2016000739A5/ja
Application granted granted Critical
Publication of JP6404186B2 publication Critical patent/JP6404186B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015139845A 2009-08-27 2015-07-13 無水形態のピリジン誘導体 Active JP6404186B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23743509P 2009-08-27 2009-08-27
US61/237,435 2009-08-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012526048A Division JP2013503134A (ja) 2009-08-27 2010-08-25 無水形態のピリジン誘導体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017114602A Division JP2017193564A (ja) 2009-08-27 2017-06-09 無水形態のピリジン誘導体

Publications (3)

Publication Number Publication Date
JP2016000739A JP2016000739A (ja) 2016-01-07
JP2016000739A5 true JP2016000739A5 (https=) 2017-08-10
JP6404186B2 JP6404186B2 (ja) 2018-10-10

Family

ID=42790943

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012526048A Pending JP2013503134A (ja) 2009-08-27 2010-08-25 無水形態のピリジン誘導体
JP2015139845A Active JP6404186B2 (ja) 2009-08-27 2015-07-13 無水形態のピリジン誘導体
JP2017114602A Pending JP2017193564A (ja) 2009-08-27 2017-06-09 無水形態のピリジン誘導体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012526048A Pending JP2013503134A (ja) 2009-08-27 2010-08-25 無水形態のピリジン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017114602A Pending JP2017193564A (ja) 2009-08-27 2017-06-09 無水形態のピリジン誘導体

Country Status (17)

Country Link
US (1) US8796269B2 (https=)
EP (1) EP2470545B1 (https=)
JP (3) JP2013503134A (https=)
KR (1) KR20120056258A (https=)
CN (1) CN102639536B (https=)
AU (1) AU2010288502B2 (https=)
CA (1) CA2772168C (https=)
DK (1) DK2470545T3 (https=)
EA (1) EA021411B1 (https=)
ES (1) ES2440938T3 (https=)
IL (1) IL217922A (https=)
IN (1) IN2012DN01292A (https=)
MX (1) MX2012002369A (https=)
PL (1) PL2470545T3 (https=)
SG (1) SG178231A1 (https=)
WO (1) WO2011023733A1 (https=)
ZA (1) ZA201200812B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102639536B (zh) * 2009-08-27 2015-03-18 尼尔医疗有限公司 吡啶衍生物的无水晶型
WO2015200594A2 (en) 2014-06-25 2015-12-30 Emory University Methods of managing conditioned fear with neurokinin receptor antagonists
EP3574907B1 (en) * 2015-05-18 2023-08-23 KaNDy Therapeutics Limited A dual nk-1/nk-3 receptor antagonist for the treatment of sex-hormone-dependent diseases
CA3044773A1 (en) * 2016-12-15 2018-06-21 Glaxosmithkline Intellectual Property Development Limited Nrf2 activators
JP7433252B2 (ja) * 2018-03-14 2024-02-19 キャンディ・セラピューティクス・リミテッド Nk-1/nk-3受容体二重アンタゴニストを含む新規な医薬製剤
WO2021030335A1 (en) * 2019-08-12 2021-02-18 Millendo Therapeutics, Inc. A stereoisomerically pure nk-3 receptor antagonist and crystalline forms thereof
KR102950227B1 (ko) 2019-11-15 2026-04-08 칸디 테라퓨틱스 리미티드 Nt-814의 핵심 중간체인 6-클로로-4-(4-플루오로-2-메틸페닐)피리딘-3-아민의 새로운 화학적 제조 방법
EP4431512A1 (en) 2023-03-16 2024-09-18 Bayer Consumer Care AG Novel dual nk-1/nk-3 receptor antagonists
WO2025242584A1 (en) 2024-05-24 2025-11-27 Bayer Consumer Care Ag A stable soft gelatin capsule formulation for elinzanetant
WO2025242585A1 (en) 2024-05-24 2025-11-27 Bayer Consumer Care Ag Crystalline forms of salts of elinzanetant and compositions containing salts of elinzanetant
WO2025242583A1 (en) 2024-05-24 2025-11-27 Bayer Consumer Care Ag Novel formulation comprising elinzanetant in a solid dispersion
WO2025261856A1 (en) * 2024-06-18 2025-12-26 Bayer Consumer Care Ag Improved process for producing an elinzanetant precursor
US12533358B1 (en) 2025-05-14 2026-01-27 Bayer Consumer Care Ag Methods of treatment with elinzanetant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1394150B1 (en) * 1999-02-24 2011-01-19 F. Hoffmann-La Roche AG 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists
GB0203022D0 (en) * 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
ATE366576T1 (de) * 2003-01-31 2007-08-15 Hoffmann La Roche Neue kristallmodifikation von 2-(3,5-bis- trifluormethyl-phenyl)-n-6-(1,1-dioxo-1lamda-6-
SI1643998T1 (sl) * 2003-07-03 2007-12-31 Hoffmann La Roche Dvojni nk1/nk3 antagonisti za zdravljenje shizofrenije
EP1928886B1 (en) * 2005-09-09 2011-04-13 GlaxoSmithKline LLC Pyridine derivatives and their use in the treatment of psychotic disorders
WO2009087667A2 (en) * 2007-12-11 2009-07-16 Cipla Ltd. A new method for preparation of zopiclone and its polymorphs
GB0814340D0 (en) * 2008-08-05 2008-09-10 Smithkline Beecham Corp Anhydrous crystol form fo a pyridine derivative
CN102639536B (zh) * 2009-08-27 2015-03-18 尼尔医疗有限公司 吡啶衍生物的无水晶型
JP6342662B2 (ja) * 2014-01-29 2018-06-13 京セラ株式会社 ドリルおよびそれを用いた切削加工物の製造方法

Similar Documents

Publication Publication Date Title
JP2016000739A5 (https=)
JP2018024682A5 (https=)
JP2021530565A5 (https=)
HRP20192132T1 (hr) Antagonist nk-1/nk-3 receptora za liječenje valunga
JP2018024670A5 (https=)
JP2019194236A5 (https=)
JP2011518833A5 (https=)
JP2016065042A5 (https=)
JP2017505347A5 (https=)
JP2018521020A5 (https=)
JP2012107057A5 (https=)
JP2016520672A5 (https=)
JP2009535462A5 (https=)
JP2009149903A5 (https=)
JP2014530818A5 (https=)
JP2011510079A5 (https=)
JP2013521273A5 (https=)
JP2012531408A5 (https=)
JP2013509391A5 (https=)
JP2011037885A5 (https=)
JP2015129106A5 (https=)
JP2018030858A5 (https=)
JP2016531079A5 (https=)
JP2015506987A5 (https=)
JP2016530311A5 (https=)